Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7776
CALL
Powell Industries
POWL
$7.4B
| $699K | ﹤0.01% |
89,700
+32,700
| +57% | +$256K |
|
7777
Comscore
SCOR
$87M
| $699K | ﹤0.01% |
16,979
+15,032
| +772% | +$625K |
|
|
ORGN
7778
CALL
DELISTED
Origin Materials
ORGN
| $698K | ﹤0.01% |
4,543
-3,494
| -43% | -$666K |
|
7779
Rhythm Pharmaceuticals
RYTM
$8B
| $698K | ﹤0.01% |
168,058
-81,866
| -33% | -$448K |
|
7780
Teekay
TK
$1.13B
| $698K | ﹤0.01% |
242,288
+175,917
| +265% | +$576K |
|
7781
Amplify AI Powered Equity ETF
AIEQ
$123M
| $697K | ﹤0.01% |
23,084
+8,229
| +55% | +$277K |
|
7782
CALL
Kornit Digital
KRNT
$740M
| $697K | ﹤0.01% |
22,000
-16,300
| -43% | -$862K |
|
7783
CALL
La-Z-Boy
LZB
$1.66B
| $697K | ﹤0.01% |
29,400
+19,200
| +188% | +$494K |
|
|
JBTM
7784
PUT
JBT Marel
JBTM
$6.05B
| $696K | ﹤0.01% |
6,300
+4,500
| +250% | +$517K |
|
|
ADN
7785
CALL
DELISTED
Advent Technologies
ADN
| $695K | ﹤0.01% |
9,193
+7,806
| +563% | +$471K |
|
7786
PUT
CrossAmerica Partners
CAPL
$925M
| $695K | ﹤0.01% |
+34,300
| New | +$724K |
|
7787
Cerus
CERS
$570M
| $695K | ﹤0.01% |
131,384
-583,333
| -82% | -$2.91M |
|
7788
CALL
Under Armour Class C
UA
$2.16B
| $695K | ﹤0.01% |
91,700
-600
| -0.7% | -$6.75K |
|
7789
CALL
1-800-Flowers.com
FLWS
$255M
| $693K | ﹤0.01% |
72,900
+14,200
| +24% | +$157K |
|
|
OBE
7790
CALL
Obsidian Energy
OBE
$771M
| $693K | ﹤0.01% |
+89,500
| New | +$792K |
|
7791
PUT
AST SpaceMobile
ASTS
$20.3B
| $692K | ﹤0.01% |
110,200
-11,800
| -10% | -$92.5K |
|
7792
PUT
Customers Bancorp
CUBI
$2.74B
| $692K | ﹤0.01% |
20,400
+6,800
| +50% | +$276K |
|
7793
CALL
Erie Indemnity
ERIE
$13.5B
| $692K | ﹤0.01% |
3,600
+400
| +13% | +$69.6K |
|
7794
Fidelity Preferred Securities & Income ETF
FPFD
$80.4M
| $692K | ﹤0.01% |
+34,362
| New | +$728K |
|
7795
First Trust Low Duration Strategic Focus ETF
LDSF
$163M
| $692K | ﹤0.01% |
+36,980
| New | +$705K |
|
7796
PUT
Schwab US TIPS ETF
SCHP
$16.3B
| $692K | ﹤0.01% |
24,800
+12,800
| +107% | +$371K |
|
|
AGIG
7797
Abundia Global Impact Group
AGIG
$40M
| $691K | ﹤0.01% |
+15,041
| New | +$653K |
|
|
HAAC
7798
PUT
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $691K | ﹤0.01% |
69,900
-23,200
| -25% | -$229K |
|
7799
Banco de Chile
BCH
$20.8B
| $690K | ﹤0.01% |
37,851
-7,765
| -17% | -$157K |
|
7800
Horizon Bancorp
HBNC
$1.03B
| $690K | ﹤0.01% |
39,615
-50,312
| -56% | -$895K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.